BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29896674)

  • 1. Signal Transduction Pathways Associated with KSHV-Related Tumors.
    Watanabe T; Sugimoto A; Hosokawa K; Fujimuro M
    Adv Exp Med Biol; 2018; 1045():321-355. PubMed ID: 29896674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KSHV Genome Replication and Maintenance in Latency.
    Ueda K
    Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
    Watanabe T; Fujimuro M
    Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
    Rivera-Soto R; Dissinger NJ; Damania B
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
    Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
    Li S; Bai L; Dong J; Sun R; Lan K
    Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis.
    Yan L; Majerciak V; Zheng ZM; Lan K
    Virol Sin; 2019 Apr; 34(2):135-161. PubMed ID: 31025296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
    Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Katano H
    Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kaposi's sarcoma-associated herpesvirus and mechanisms of oncogenesis].
    Fujimuro M
    Uirusu; 2006 Dec; 56(2):209-18. PubMed ID: 17446670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.
    Cai Q; Verma SC; Lu J; Robertson ES
    Adv Virus Res; 2010; 78():87-142. PubMed ID: 21040832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
    Cathomas G
    Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection
    Muniraju M; Mutsvunguma LZ; Reidel IG; Escalante GM; Cua S; Musonda W; Calero-Landa J; Farelo MA; Rodriguez E; Li Z; Ogembo JG
    J Virol; 2024 Jun; 98(6):e0057624. PubMed ID: 38767375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
    Kalt I; Masa SR; Sarid R
    Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
    Viejo-Borbolla A; Schulz TF
    AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.
    Naimo E; Zischke J; Schulz TF
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular pathology of Kaposi's sarcoma-associated herpesvirus.
    Jenner RG; Boshoff C
    Biochim Biophys Acta; 2002 Mar; 1602(1):1-22. PubMed ID: 11960692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
    Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.